Following its initial reports of the 2018, 2020, 2023, and 2024 Healthcare Monitor, the Worldcom PR Group has changed dramatically. In previous versions, we calculated rankings based on a point system. For this fifth edition, our experts have now decided to take a different approach and take a deep dive into communication enablers and messaging for the top 10 pharmaceutical companies in the world.

This report has been drafted in response to a clear reality: communication is changing fundamentally. With the rise and influence of Artificial Intelligence (AI), expectations regarding clarity, trust, relevance, and digital findability are increasing across all sectors. At the same time, the way the public finds and evaluates information is being reshaped by new technologies, new channels, and new habits. In this environment, organizations need stricter standards for effective communication.

There were four areas of focus that contributed to the report including:

1. Generative Engine Optimization: As AI-driven search reshapes discovery, brands must now compete not just for clicks but for citation within generated answers. The report tracks awareness, share of voice, mention position, and sentiment across leading generative platforms.
2. Digital Infrastructure & Governance: Corporate websites are no longer brochures — they are strategic trust assets. A crawl-based analysis of all ten companies reveals how governance, findability, architecture, and efficiency determine credibility at scale.
3. Audience Targeting & Message Fit: Effective communication requires more than translation — it demands audience-specific messaging, local readability calibration, and content designed for the decision each stakeholder is actually trying to make
4. Conversation Themes & Visibility: Pharma brands don’t control the conversation, but they can shape it. The report maps positioning themes, visibility clusters, and the gap between owned content priorities and what trade media, daily newspapers, and AI systems actually surface.